Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
In the synthetic biology sector
Electra received $5 million from the Canadian government
Roivant halted further development of namilumab for this ailment
These sources ensure trustworthy strategic insights
The first-party data market was valued at $19
ARMORY PORTER'S FIVE FORCES TEMPLATE RESEARCH B_135 In the synthetic biology sectorWhat is included in the product Detailed Word Document Tailored exclusively for Armory, analyzing its position within its competitive landscape. Customizable Excel Spreadsheet Customize pressure levels based on new data or evolving market trends. Full Version Awaits Armory Porter's Five Forces Analysis This preview is the complete Armory Porter's Five Forces analysis. It assesses industry competitiveness. The factors examined are: threats of new
US$ 78.00
US$ 145.00
US$ 50.00
US$ 88.00
US$ 45.00
US$ 120.00
